NCT01754857 2023-06-27Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLLUniversity of Wisconsin, MadisonPhase 2 Completed36 enrolled 11 charts
NCT01520922 2017-01-19Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)NovartisPhase 2 Completed99 enrolled 27 charts